NONSEGMENTAL VITILIGO
Clinical trials for NONSEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NONSEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NONSEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cream trial aims to bring back skin color for kids with vitiligo
Disease control Recruiting nowThis study is testing whether a cream called ruxolitinib is safe and effective at helping skin regain its natural color in children aged 6 to 12 with nonsegmental vitiligo. About 250 children will apply the cream or a placebo to see if it reduces the white patches on their face a…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New skin pigment drug tested for vitiligo treatment
Disease control Recruiting nowThis study is testing whether adding an investigational drug called Melanotan II to standard narrowband UV-B light therapy helps restore skin color in adults with stable vitiligo. Sixty participants will receive either the drug or a placebo along with light therapy for 24 weeks. …
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New pill aims to restore skin color in vitiligo patients
Disease control Recruiting nowThis study is testing an oral medication called zasocitinib to see if it can help restore skin color in adults with nonsegmental vitiligo, an autoimmune condition that causes white patches on the skin. About 200 participants will be randomly assigned to receive either the study d…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
New cream could help restore skin color for kids with vitiligo
Disease control Recruiting nowThis study is testing whether a cream called ruxolitinib is safe and effective at helping restore skin color in children with nonsegmental vitiligo. It will involve about 180 children and is a late-stage (Phase 3) trial. The main goal is to see if the cream can improve the appear…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC